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Stent  for  Life
Abstract
Introduction  and  Aims:  System  delay  (time  between  first  medical  contact  and  reperfusion
therapy) is  an  indicator  of  quality  of  primary  percutaneous  coronary  intervention  (pPCI)  in
ST-segment  elevation  myocardial  infarction  (STEMI)  patients.  This  study  aimed  to  assess  changes
in system  delay  between  2011  and  2015,  and  to  identify  its  predictors.
Methods:  The  study  included  838  patients  admitted  to  18  Portuguese  interventional  cardiology
centers suspected  of  having  STEMI  with  less  than  12  hours’  duration  who  were  referred  for
primary percutaneous  coronary  intervention.  Data  were  collected  for  a  one-month  period  every
year from  2011  to  2015.  Univariate  and  multivariate  logistic  regression  models  were  used  to
determine  predictors  of  system  delay.
Results:  No  significant  changes  in  system  delay  were  observed  during  the  study.  Only  27%  of
patients had  a  system  delay  of  ≤90  min.  Multivariate  analysis  identified  four  predictors  of  system
57;  95%  CI  1.50-4.59;  p=0.001),  attending  a  center  without  pPCI  (OR
.001),  not  calling  the  national  medical  emergency  number  (112)  (OR
.001),  and  Central  region  (OR  3.43;  95%  CI  1.60-8.31;  p=0.003).delay: age  ≥75  years  (OR  2.
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Conclusions:  The  factors  age  ≥75  years,  attending  a  center  without  pPCI,  not  calling  112,  and
Central region  were  identified  as  predicting  longer  system  delay.  This  knowledge  may  help  in
planning interventions  to  reduce  system  delay  and  to  improve  the  clinical  outcomes  of  patients
with STEMI.
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Iniciativa  Stent  for  Life: fatores  preditivos  de  atraso  do  sistema  em  doentes
com  enfarte  do  miocárdio  com  supradesnivelamento  do  segmento  ST
Resumo
Introdução  e  objetivos:  O  «Atraso  do  Sistema» (tempo  decorrido  entre  o  primeiro  contacto
médico e  a  terapêutica  de  reperfusão)  tem  sido  considerado  um  indicador  de  qualidade  na
angioplastia  primária  (P-PCI)  em  doentes  com  enfarte  do  miocárdio  com  supradesnivelamento
do segmento  ST  (STEMI).  Este  estudo  tem  como  objetivo  estudar  a  evolução  das  características
do atraso  do  sistema  entre  2011  e  2015  e  identificar  os  seus  preditores.
Métodos:  O  estudo  incluiu  838  doentes  com  suspeita  de  STEMI  com  menos  de  12  horas  de
evolução e  propostos  para  angioplastia  primária,  que  foram  admitidos  em  18  centros  portugue-
ses de  cardiologia  de  intervenção.  Estes  dados  foram  recolhidos  durante  um  mês  por  ano,  entre
2011 e  2015.  Modelos  de  regressão  linear  univariável  e  multivariável  foram  usados  para  iden-
tificar os  fatores  preditivos  do  atraso  do  sistema.  Ao  longo  do  estudo,  não  foram  observadas
diferenças significativas  no  atraso  do  sistema.
Resultados:  Apenas  27%  dos  doentes  obtiveram  um  atraso  do  sistema  <90  minutos.  A  análise
multivariável  encontrou  quatro  preditores  de  atraso  do  sistema:  idade  ≥  75  anos  (OR  2,57;
CI95% 1,50-4,59;  p=0,001),  entrada  num  centro  sem  P-PCI  (OR  4,08;  CI95%  2,75-6,10;  p<0,001),
ligar 112-  EMS  (OR  0,47;  CI95%  0,32-0,68;  p<0,001)  e  Região  «Centro» (OR  3,43;  CI95%  1,60-8,31;
p=0,003).
Conclusões:  Os  fatores  «idade  >75  anos»,  «entrada  num  centro  sem  P-PCI»,  não  «ligar  para  o
112-SEM» e  «Região  Centro» foram  identificados  como  fatores  preditores  para  maior  atraso  no
sistema.  O  conhecimento  destes  fatores  permitirá  programar  intervenções  que  visem  reduzir  o
atraso do  sistema  e  melhorar  os  resultados  dos  doentes  com  STEMI.






















CI  confidence  interval
ECG  electrocardiogram
EMS  emergency  medical  services
FMC  first  medical  contact
IQR  interquartile  range
MI  myocardial  infarction
OR  odds  ratio
pPCI  primary  percutaneous  coronary  intervention
SFL  Stent  for  Life
STEMI  ST-segment  elevation  myocardial  infarction
ntroduction
rimary  angioplasty  is  the  best  treatment  for  ST-segment
levation  myocardial  infarction  (STEMI)  patients.1--4 How-
ver,  even  in  the  most  developed  countries,  with  a  national





nd  highly  skilled  teams  working  24/7,  primary  percu-
aneous  coronary  intervention  (pPCI)  is  rarely  achieved
ithin  120  min  of  symptom  onset.  Efforts  therefore  need
o  be  made  to  enable  better  access  to  pPCI.  For  this
urpose,  it  is  essential  to  audit,  monitor  and  assess  coro-
ary  networks.  Primary  angioplasty  should  be  conducted
ithin  12  hours  of  symptom  onset,  but  the  greatest
enefits  are  achieved  if  pPCI  is  performed  within  two
ours.1,2,4,5
Total  ischemic  time,  defined  as  time  from  symptom  onset
o  reperfusion,  is  a  well-established  prognostic  factor  in
TEMI  patients.6-9 It  is  divided  into  two  main  periods,  time
rom  symptom  onset  to  first  medical  contact  (FMC)  (patient
elay),  and  time  from  FMC  to  pPCI  (system  delay).4,10
The  guidelines  suggest  door-to-balloon  time  (time  from
rrival  at  a  pPCI  center  to  beginning  of  pPCI)  as  a  measure  to
ssess  the  hospital’s  performance  in  STEMI  treatment.1,4,11
owever,  other  studies  have  reported  that  reducing  this
ime  does  not  positively  impact  mortality11 and  that  delays


















































Factors  predicting  system  delay  in  STEMI  
Studies  have  reported  that  longer  system  delay  is  asso-
ciated  with  higher  mortality  and  morbidity  rates  in  STEMI
patients.7,14--16
Stent  for  Life  (SFL)  is  an  initiative  by  the  European  Associ-
ation  of  Percutaneous  Cardiovascular  Interventions  and  the
European  Society  of  Cardiology  designed  to  improve  the
treatment  of  STEMI  patients  and  to  reduce  STEMI-related
mortality.  SFL  aims  to  increase  the  number  of  STEMI  patients
treated  by  pPCI  in  countries  that  join  the  initiative  and  to
ensure  that  centers  are  able  to  perform  pPCI  24/7.17 Portu-
gal  has  been  part  of  this  initiative  since  201118 and  currently
18  centers  in  mainland  Portugal  perform  pPCI  procedures
24/7.
Various  factors  influence  system  delay.  Importantly,  fail-
ure  to  contact  the  emergency  medical  services  (EMS)  and
off-hours  presentation  lead  to  longer  system  delay.19
In  the  last  decade,  pPCI  rates  in  Portugal  were  among  the
lowest  in  Western  Europe,  though  in  recent  years  the  pro-
cedure  has  been  performed  more  frequently  in  Portuguese
hospitals,  suggesting  that  the  country’s  participation  in  the
SFL  initiative  has  had  a  positive  impact.20
This  paper  aims  to  assess  changes  in  system  delay  since
Portugal  joined  SFL,  to  identify  factors  that  influence  this
time,  and  to  identify  areas  of  intervention  designed  to
improve  care  of  STEMI  patients.
Methods
Study  design  and  data  collection
The  study  population  was  composed  of  838  patients  sus-
pected  of  having  STEMI  with  less  than  12  hours’  duration  who
were  referred  for  pPCI  and  admitted  to  one  of  the  18  inter-
ventional  cardiology  centers  in  mainland  Portugal  that  have
24/7  pPCI  and  participate  in  the  National  Registry  of  Inter-
ventional  Cardiology  (RNCI)  and  the  Portuguese  Registry  of
Acute  Coronary  Syndromes  (ProACS).  The  diagnosis  of  STEMI
was  confirmed  in  90.5%  of  cases.
The  study  was  based  on  a  national  survey  involving  these
centers  under  the  aegis  of  the  Portuguese  Association  of
Interventional  Cardiology  (APIC).  For  a  one-month  period,
every  year  from  2011  to  2015,  all  patients  with  STEMI  who
underwent  coronary  angiography  at  the  participating  cen-
ters  were  enrolled  in  the  study.  The  survey  was  carried  out
at  five  time  points:  from  May  9  to  June  8,  2011,  immedi-
ately  after  Portugal  joined  SFL  (time  zero,  T0),  and  at  the
same  point  in  2012  (time  one,  T1),  2013  (time  two,  T2),
2014  (time  three,  T3)  and  2015  (time  four,  T4).  STEMI  was
defined  according  to  the  universal  definition  of  myocardial
infarction.21 FMC  was  defined  as  the  time  of  arrival  of  medi-
cal  and/or  paramedical  staff  to  attend  the  patient  or  the
time  of  arrival  at  a  hospital  for  fibrinolysis  or  pPCI.
Patients  who  received  fibrinolytic  therapy  prior  to  pPCI,
presented  with  in-hospital  STEMI,  were  admitted  in  the
autonomous  regions  of  Madeira  and  the  Azores,  had  late
STEMI  presentation  (more  than  12  hours  after  symptom
onset),  or  did  not  present  ST  elevation  on  the  electrocar-
diogram,  were  excluded  from  the  study.
Demographic  and  clinical  data  were  collected.  System
delay  was  considered  as  a  continuous  or  categorical  variable,






sed  were  120  min  for  total  ischemic  time,  90  min  for  sys-
em  delay,  60  min  for  door-to-balloon  time  and  10  min  for
MC-to-electrocardiogram  (ECG)  time.
tatistical  analysis
he  normality  of  data  was  assessed  by  the  Shapiro-Wilk  test.
s  system  delay  values  were  skewed,  they  were  described
sing  medians  and  interquartile  range  (IQR)  and  tested  using
he  Mann-Whitney  U  test  and  the  Kruskal-Wallis  test  for
wo  or  more  independent  samples,  respectively.  Addition-
lly,  considering  system  delay  as  a  categorical  variable  (≤90
in),  number  and  percentage  were  used  to  summarize  this
ariable  and  differences  between  groups  were  assessed  by
he  chi-square  test  or  Fisher’s  exact  test.
For  categorical  data,  differences  between  groups  were
ssessed  by  the  chi-square  test  or  Fisher’s  exact  test.
or  continuous  and  normally  distributed  data,  differ-
nces  between  two  or  more  groups  were  assessed
y  the  Student’s  t  test  or  ANOVA,  respectively.  For  non-
ormally  distributed  data,  the  Mann-Whitney  test  or  the
ruskal-Wallis  test  were  used.
Considering  system  delay  as  a  categorical  outcome,  its
ssociation  with  each  potential  predictive  factor  was  first
ested  in  a  univariate  logistic  regression  model.  Multivari-
te  logistic  regression  models  were  then  used  to  determine
ariables  independently  associated  with  system  delay,  con-
idering  all  significant  predictive  factors  identified  in  the
nivariate  model.  Odds  ratios  (OR)  and  95%  confidence  inter-
als  (CIs)  were  reported.  The  analysis  was  conducted  at  a  5%
evel  of  significance.  All  statistical  analyses  were  performed
sing  R  software,  version  3.1.0.22
esults
he  sample  comprised  838  patients  who  underwent  pPCI
etween  2011  (T0)  and  2015  (T4).  Patient  characteristics
ver  the  years  are  summarized  in  Table  1.  In  the  last  year
T4),  patients  included  in  the  analysis  were  older  (p=0.048)
nd  had  a  higher  prevalence  of  diabetes  compared  to  pre-
ious  years  (p=0.032).  Although  the  percentage  of  patients
ho  called  the  national  medical  emergency  number  (112)
id  not  change,  the  number  of  patients  admitted  to  a  pPCI
enter  through  the  EMS  tended  to  increase.  By  contrast,
here  was  a  downward  trend  in  the  proportion  of  patients
ransferred  from  local  hospitals  without  pPCI  facilities.  Of
he  319  patients  with  suspected  STEMI  who  called  112,  only
69  (53%)  were  in  fact  transported  by  the  EMS  (Table  1).
Considering  only  the  patients  transferred  (n=379),  there
ere  differences  between  the  time  points  in  those  trans-
erred  by  EMS  from  another  hospital  to  the  pPCI  center
inter-hospital  transport:  21%  vs.  secondary  transport:  79%)
p<0.001).  The  percentage  of  patients  using  secondary  trans-
ort  decreased  throughout  the  survey  (data  not  shown).
Table  2
presents  the  characteristics  of  system  delay  (FMC-to-ECG
ime,  door-to-balloon  time,  system  delay  and  total  ischemic
ime)  for  the  different  time  points.  No  differences  were
ound  between  the  four  time  points.  The  percentage  of
atients  with  FMC-to-ECG  time  <10  min  was  less  than  50%








Table  1  Characteristics  of  the  study  population  at  the  different  time  points  of  the  survey.
Variable Total T0 T1 T2 T3 T4 p
Total, n (%) 838 157 (18.7) 151 (18.0) 173 (20.6) 195 (23.3) 162 (19.3)
Region, n (%) North 297 66 (42.0) 54 (35.8) 59 (34.1) 63 (32.3) 55 (34.0) 0.009
Central 79 22 (14.0) 11 (7.3) 10 (5.8) 14 (7.2) 22 (13.6)
Lisbon and Tagus Valley 376 59 (37.6) 71 (47.0) 78 (45.1) 97 (49.7) 71 (43.8)
Algarve 55 10 (6.4) 12 (7.9) 14 (8.1) 10 (5.1) 9 (5.6)
Alentejo 31 0  (0.0) 3 (2.0) 12 (6.9) 11 (5.6) 5 (3.1)
Gender, n (%) Male  649 129 (82.2) 119 (82.1) 128 (74.9) 158 (82.7) 115 (72.8) 0.066
Female 173 28 (17.8) 26 (17.9) 43 (25.1) 33 (17.3) 43 (27.2)
Age, years n  (%) 838 155 (18.8) 146 (17.7) 171 (20.7) 193 (23.4) 160 (19.4)
Mean (SD) 62.1 (13.3) 62.5 (13.7) 60.8 (13.0) 62.8 (13.2) 60.2 (14.0) 64.3 (12.3) 0.040
Median (IQR) 61.0 (53.0-71.0) 63.0 (53.0-72.5) 59.0 (52.2-69.0) 60.0 (54.0-71.0) 60.0 (50.0-69.0) 63.0 (55.0-73.0) 0.048
Median (min-max) 61.0 (1.0-95.0) 63.0 (28.0-95.0) 59.0 (33.0-94.0) 60.0 (19.0-89.0) 60.0 (1.0-94.0) 63.0 (35.0-90.0)
CV (%) 21.4 21.9 21.3 21.0 23.3 19.1
Categorized age, n (%) <75  years 671 125 (80.6) 123 (84.2) 138 (80.7) 162 (83.9) 123 (76.9) 0.424
≥75 years 154 30 (19.4) 23 (15.8) 33 (19.3) 31 (16.1) 37 (23.1)
History of PCI, n (%) no  730 136 (88.9) 129 (88.4) 150 (87.2) 173 (89.6) 142 (89.9) 0.940
yes 92 17 (11.1) 17 (11.6) 22 (12.8) 20 (10.4) 16 (10.1)
History of CABG, n (%) no  810 150 (99.3) 145 (99.3) 172 (100.0) 190 (97.9) 153 (98.1) -
yes 9 1  (0.7) 1 (0.7) 0 (0.0) 4 (2.1) 3 (1.9)
History of MI, n (%) no  726 133 (89.3) 127 (87.0) 150 (87.2) 172 (88.7) 144 (91.7) 0.682
yes 92 16 (10.7) 19 (13.0) 22 (12.8) 22 (11.3) 13 (8.3)
History of diabetes, n (%) no  651 127 (86.4) 115 (78.2) 134 (77.9) 161 (83.4) 114 (73.1) 0.032
yes 164 20 (13.6) 32 (21.8) 38 (22.1) 32 (16.6) 42 (26.9)
Called 112, n (%) no  507 96 (64.4) 90 (59.6) 110 (64.3) 115 (59.3) 96 (59.6) 0.739
yes 319 53 (35.6) 61 (40.4) 61 (35.7) 79 (40.7) 65 (40.4)
Hospital triage, n (%) Not  applicable 175 22 (14.5) 45 (31.9) 38 (23.3) 36 (19.0) 34 (21.8) -
Manchester 617 130 (85.5) 96 (68.1) 120 (73.6) 151 (79.9) 120 (76.9)
Other 9 0  (0.0) 0 (0.0) 5 (3.1) 2 (1.1) 2 (1.3)
Triage classification, n (%) Red 48 7  (5.8) 11 (11.7) 8 (6.8) 17 (11.3) 5 (4.3) 0.020
Orange 425 93 (76.9) 64 (68.1) 92 (78.0) 101 (67.3) 75 (64.1)
Yellow or other 127 21 (17.4) 19 (20.2) 18 (15.3) 32 (21.3) 37 (31.6)
FMC during off-hours, n (%) No  383 74 (51.4) 65 (43.0) 79 (45.7) 91 (46.7) 74 (45.7) 0.699
Yes 442 70 (48.6) 86 (57.0) 94 (54.3) 104 (53.3) 88 (54.3)
Attending a center without pPCI after
FMC (secondary transport), n (%)
No 443 72 (45.9) 81 (53.6) 89 (51.4) 109 (55.9) 92 (56.8) 0.288
Yes 395 85 (54.1) 70 (46.4) 84 (48.6) 86 (44.1) 70 (43.2)
Means of transport to pPCI facility, n
(%)
Other means of transport 395 85 (54.1) 70 (46.4) 84 (48.6) 86 (44.1) 70 (43.5) 0.058
EMS from primary healthcare,
home or outdoors
169  15 (9.6) 36 (23.8) 37 (21.4) 44 (22.6) 37 (23.0)
Direct to the pPCI center
(non-EMS)
273  57 (36.3) 45 (29.8) 52 (30.1) 65 (33.3) 54 (33.5)
Diagnosis after team activation, n (%) STEMI  829 156 (99.4) 151 (100.0) 169 (97.7) 192 (98.5) 161 (99.4) -
No significant coronary lesions 3 1  (0.6) 0 (0.0) 2 (1.2) 0 (0.0) 0 (0.0)
Myopericarditis 4 0  (0.0) 0 (0.0) 0 (0.0) 3 (1.5) 1 (0.6)
Tako-tsubo syndrome 2 0  (0.0) 0 (0.0) 2 (1.2) 0 (0.0) 0 (0.0)
p: for difference between groups using a non-parametric Kruskal-Wallis test.
CABG: coronary artery bypass grafting; CV: coefficient of variation; ECG: electrocardiogram; EMS: emergency medical services; FMC: first medical contact; IQR: interquartile range; MI:
myocardial infarction; min-max: minimum-maximum; pPCI: primary percutaneous coronary intervention; SD: standard deviation; STEMI: ST-segment elevation myocardial infarction; T0:










Table  2  Characterization  of  system  delay  and  other  times  that  influence  system  delay  over  the  different  time  points  of  the  survey.
Variable Total T0  T1  T2  T3  T4  p
Total n  (%) 838  157  (18.7) 151  (18.0) 173  (20.6) 195  (23.3) 162  (19.3)
FMC-to-ECG time,
min
n  (%) 838  131  (17.9) 136  (18.6) 151  (20.7) 170  (23.3) 142  (19.5)
Median (IQR) 13.0  (5.2-30.0) 16.0  (7.5-39.0) 13.0  (5.0-30.0) 12.0  (7.0-29.5) 12.5  (5.0-29.8) 13.0  (5.0-28.8) 0.421
FMC-to-ECG time
≤10  min,  n  (%)
No  418  86  (65.6) 80  (58.8) 84  (55.6) 90  (52.9) 78  (54.9) 0.225
Yes 312 45  (34.4) 56  (41.2) 67  (44.4) 80  (47.1) 64  (45.1)
Door-to-balloon  time,
min
n  (%) 838  156  (18.7) 147  (17.6) 173  (20.8) 195  (23.4) 162  (19.4)
Median (IQR) 55.0  (30.0-95.0) 54.0  (30.0-96.8) 50.0  (33.5-96.0) 57.0  (30.0-83.0) 57.0  (28.0-101.0) 64.0  (30.0-100.0) 0.883
Door-to-balloon  time
≤60  min,  n  (%)
No  382  68  (43.6) 64  (43.5) 76  (43.9) 91  (46.7) 83  (51.2)  0.585
Yes 451 88  (56.4) 83  (56.5) 97  (56.1) 104  (53.3) 79  (48.8)
System delay,  min n  (%) 838  157  (18.7) 151  (18.0) 173  (20.6) 195  (23.3) 162  (19.3)
Median (IQR) 124.0  (89.0-192.0) 115.0  (79.0-179.0) 125.0  (92.5-186.0) 115.0  (87.0-189.0) 130.0  (91.0-217.0) 127.0  (92.5-203.8) 0.304
System delay  ≤90  min,
n (%)
no  616  107  (68.2) 114  (75.5) 122  (70.5) 147  (75.4) 126  (77.8) 0.260
yes 222  50  (31.8) 37  (24.5) 51  (29.5) 48  (24.6) 36  (22.2)
Total ischemic  time,
min
n  (%) 838  157  (19.0) 150  (18.1) 172  (20.8) 191  (23.1) 158  (19.1)
Median (IQR) 250.0  (171.0-408.5) 250.0  (180.0-421.0) 247.0  (165.0-352.0) 260.5  (165.0-392.2) 240.0  (165.5-430.5) 263.5  (179.2-441.0) 0.542
Total ischemic  time
≤120  min,  n  (%)
No  758  144  (91.7) 132  (88.0) 157  (91.3) 176  (92.1) 149  (94.3) 0.393
Yes 70 13  (8.3) 18  (12.0) 15  (8.7) 15  (7.9) 9  (5.7)
p: for difference between groups using a non-parametric test (Kruskal-Wallis).
Door-to-balloon time: time from arrival at a primary percutaneous coronary intervention center to beginning of procedure; ECG: electrocardiogram; FMC: first medical contact; IQR:
interquartile range; System delay: time between first medical contact and reperfusion therapy; T0: time zero, 2011; T1: time one, 2012; T2: time two, 2013; T3: time three, 2014; T4:
time four, 2015; Total ischemic time: time from symptom onset to reperfusion.
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Table  3  Univariate  and  multivariate  log-linear  regression  analysis  of  predictors  of  system  delay.
Variable  n  (%)  Univariate  models  Multivariate  model
OR  (95%  CI) p  ORa (95%  CI)  pa
Time  point T0  157  (18.7)  1  -  1  -
T1 151  (18.0)  1.44  (0.88-2.38)  0.153  1.31  (0.69-2.51)  0.410
T2 173  (20.6)  1.12  (0.70-1.79)  0.641  0.87  (0.46-1.63)  0.668
T3 195  (23.3)  1.43  (0.90-2.29)  0.133  1.32  (0.71-2.44)  0.380
T4 162  (19.3)  1.70  (1.03-2.82)  0.040  1.50  (0.79-2.87)  0.215
Gender Male 649  (79.0) 1  -  1  -
Female 173  (21.0) 1.73  (1.15-2.67) 0.011 1.40  (0.88-2.29) 0.162
Categorized  age <75  years 671  (81.3) 1  -  1  -
≥75 years  154  (18.7)  2.95  (1.82-5.05)  <0.001  2.57  (1.50-4.59)  0.001
Region North 297  (35.4)  1  -  1  -
Central 79  (9.4)  3.22  (1.62-7.18)  0.002  3.43  (1.60-8.31)  0.003
Lisbon and
Tagus  Valley
376  (44.9) 1.07  (0.76-1.50)  0.697  1.38  (0.93-2.05)  0.110
Algarve 55  (6.6) 0.93  (0.50-1.76) 0.809 0.97  (0.47-2.09)  0.938
Alentejo 31  (3.7) 3.87  (1.33-16.46) 0.029 3.34  (1.05-15.01) 0.067
History of  PCI No  730  (88.8) 1  -
Yes 92  (11.2)  0.76  (0.48-1.24)  0.262
History of  MI No  726  (88.8)  1  -
Yes 92  (11.2)  0.79  (0.50-1.29)  0.338
History of  diabetes No  651  (79.9)  1  -
Yes 164  (20.1)  0.98  (0.67-1.45)  0.916
Called 112 no  507  (61.4)  1  -  1  -
yes 319  (38.6)  0.59  (0.43-0.81)  0.001  0.47  (0.32-0.68)  <0.001
Arrival by  own  means  of
transport  at  a  pPCI  center
No  221  (62.6)  1  -  (a)
Yes 132  (37.4)  0.56  (0.35-0.89)  0.013
FMC during  off-hours No  383  (46.4)  1  -
Yes 442  (53.6)  1.31  (0.96-1.79)  0.088
Attending a  center  without  pPCI  or
other  healthcare  unit  after  FMC
(patient  transferred)
No  295  (39.6)  1  -  1  -
Yes 450  (60.4)  3.35  (2.41-4.69)  <0.001  4.08  (2.75-6.10)  <0.001
Diagnosis of  STEMI  after  team
activation
No  9  (1.1)  1  -
Yes 829  (98.9)  0.35  (0.02-1.90)  0.318
a Adjusted for all the other covariates presented in the multivariate model.
CI: confidence interval; FMC: first medical contact; MI: myocardial infarction; OR: odds ratio; PCI: percutaneous coronary intervention;
pPCI: primary percutaneous coronary intervention; T0: time zero, 2011; T1: time one, 2012; T2: time two, 2013; T3: time three, 2014;






























Only significant variables were included in the multivariate mode
history of coronary artery bypass grafting was not included becau
on-significantly  from  56.4%  to  48.8%.  Two  hundred  and
wenty-two  patients  (26%)  had  a  system  delay  of  ≤90  min
nd  only  70  patients  (8%)  had  total  ischemic  time  of  ≤120
in.
To  identify  potential  factors  predicting  system  delay,  uni-
ariate  and  multivariate  logistic  regression  models  were
sed  to  analyze  a  set  of  variables  that  could  influence  the
utcome  (Table  3).  The  variables  T4,  female  gender,  age
75  years,  Central  and  Alentejo  regions,  not  calling  112,
ot  arriving  by  their  own  means  of  transport  to  a  pPCI  unit,
nd  attending  a  center  without  pPCI  or  other  healthcare  unit
fter  FMC  (patient  transferred)  were  identified  as  potential
actors  predicting  longer  system  delay  in  univariate  logis-
ic  regression  analysis  (Table  3).  Admission  during  off-hours
eriods  (nights  or  weekends)  was  not  significantly  associated




cept variables with problems of multicollinearity). The variable
e small number of cases.
nalysis,  only  age  ≥75  years,  Central  region,  not  calling  112
nd  attending  a  center  without  pPCI  remained  statistically
ignificant  predictors  of  longer  system  delay.  Medians  and
nterquartile  range  of  system  delay  are  presented  in  Figure  1
or  each  category  of  these  predictive  factors  with  p-values
rom  multivariate  logistic  regression.
Figure  2A  shows  that  there  were  no  significant  changes
n  the  number  of  patients  calling  112  over  the  different
ime  points  of  the  survey  (T0-T4)  (p=0.739).  When  stratified
ccording  to  whether  or  not  patients  called  112  (Figure  2B),
ifferences  between  the  groups  were  found  for  FMC-to-ECG
ime  (p<0.001),  system  delay  (p=0.001)  and  total  ischemic
ime  (p<0.001).  It  can  also  be  seen  that  32.9%  of  patients
alling  112  had  a  system  delay  ≤90  min,  which  is  significantly
ore  than  those  who  did  not  (22.5%).  Similarly,  consider-
ng  as  a variable  whether  the  patient  was  transferred  or

























































Attending a center without p-PCI or other healthcare 
unit after FMC (patient transferred)
A C
B D
Figure  1  Variables  that  impact  system  delay.  (A)  Age;  (B)  region;  (C)  calling  112;  (D)  attending  a  center  without  pPCI  or  other
healthcare unit  after  FMC  (patient  transferred).  Results  are  presented  as  medians  and  interquartile  range.














between patients  who  called  and  did  not  call  112.  ECG:  electr
time one,  2012;  T2:  time  two,  2013;  T3:  time  three,  2014;  T4:  
was  taken  direct  to  the  pPCI  center  by  the  EMS,  differ-
ences  were  found  for  FMC-to-ECG  time,  system  delay  and
total  ischemic  time  (Figure  3).  It  can  be  seen  that  33.1%  of
patients  transported  directly  to  a  pPCI  center  by  the  EMS  had
a  system  delay  ≤90  min  vs.  13.2%  of  patients  who  were  trans-
ferred  (p=0.001),  which  corresponds  to  20%  more  patients
who  were  within  the  recommended  system  delay  times.
Discussion
System  delay  is  one  of  the  most  important  timings  for
assessing  the  quality  of  a  system,  but  also  for  determin-
ing  which  reperfusion  strategy  should  be  used.23 Current
guidelines  suggest  pPCI  as  the  ideal  reperfusion  strategy





diogram;  FMC:  first  medical  contact;  T0:  time  zero,  2011;  T1:
 four,  2015.
ecommended  timeframes,  in  which  case  fibrinolytic
herapy  should  be  considered.  There  is,  however,  still  con-
iderable  debate  concerning  how  much  delay  is  acceptable
hen  making  this  decision,  or  when  a  combination  of  the
wo  reperfusion  methods  should  be  preferred.24,25 There  is
vidence  that  pPCI  loses  its  advantage  over  fibrinolysis  for
onger  delays  after  symptom  onset.26
Our  results  suggest  that  there  were  no  significant
mprovements  in  system  delay  between  the  beginning  of  SFL
n  Portugal  (T0)  and  2015  (T4).  Furthermore,  the  study  sug-
ests  that  the  aims  stated  in  the  current  STEMI  treatment
uidelines1,2 have  not  been  achieved  in  Portugal:  system
elay  was  over  115  min  at  all  the  time  points  of  the  study,
nd  only  33.1%  of  STEMI  patients  transported  directly  to  a
PCI  center  by  EMS  had  a  system  delay  of  90  min  or  less.  The
ituation  is  very  different  in  central  and  northern  Europe.  In
688  
Figure  3  Characterization  of  system  delay  according  to































































































PCI  center  by  the  EMS.  ECG:  electrocardiogram;  EMS:  emer-
ency  medical  services;  FMC:  first  medical  contact.
aily  practice  in  the  Netherlands,  almost  all  STEMI  patients
an  be  transported  to  a  pPCI  center  within  60  min  of  FMC
which  is  usually  the  emergency  call),27 while  in  Sweden  the
edian  FMC-pPCI  time  is  70  min.28
Univariate  analysis  of  our  results  revealed  that  six  factors
nfluence  system  delay:  age  ≥75  years,  female  gender,  Cen-
ral  and  Alentejo  regions,  and  attending  a  center  without
PCI  were  associated  with  longer  system  delay,  whereas  the
ariables  calling  112  and  arrival  by  their  own  means  of  trans-
ort  at  a  pPCI  center  were  associated  with  shorter  system
elay.  However,  the  multivariate  model  showed  that  only
he  variables  age  ≥75  years,  Central  region,  and  attending  a
enter  without  pPCI  were  predictors  of  longer  system  delay,
hereas  calling  112  was  predictive  of  shorter  system  delay.
In  view  of  these  results,  it  is  important  to  look  at  the
ay  elderly  patients  are  handled  when  they  enter  the  health
ystem.  This  segment  of  the  population  presents  specific
haracteristics  that  contribute  to  greater  system  delay.
ow  literacy  levels,  slowness  and  frailty  affect  how  these
atients  are  handled  and  transported  in  and  between  hospi-
als,  leading  to  further  delays.
The  Central  region  presents  significantly  longer  system
elays  than  other  regions  of  the  country.  One  of  the  reasons
or  this  result  may  be  the  greater  distances  in  this  region
etween  the  patient’s  location  at  the  time  of  symptom  onset
nd  the  pPCI  center.  Geographic  adjustments  in  the  STEMI
etwork  and  improvements  in  transport  (direct  to  a  pPCI
enter  and  transfer)  may  lead  to  more  equitable  access  to
PCI.
The  fact  that  there  were  more  patients  who  called  112
ith  system  delay  ≤90  min  than  those  who  did  not  may
ave  a  simple  explanation:  in  the  former  group,  the  num-
er  of  patients  who  arrive  directly  at  a  pPCI  center  and
ho  spend  no  time  in  inter-hospital  transfer  is  likely  to
e  much  higher.  The  fact  that  in  our  study  patients  who
alled  112  had  significantly  shorter  system  delay  may  be
losely  related  to  the  SFL  initiative  in  Portugal,  as  since  the
eginning  of  this  initiative,  the  EMS  started  to  contact  pPCI
enters  directly,  to  transmit  ECGs  wirelessly,  and  to  deliver
TEMI  patients  directly  to  catheterization  laboratories.  This
s  confirmed  by  the  fact  that,  in  this  study,  more  patients
ransported  by  the  EMS  had  an  FMC-to-ECG  time  of  ≤10  min
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SA  demonstrated  that  prehospital  wireless  electrocardio-
ram  transmission  reduced  system  delay.29 In  Denmark,  a
tudy  conducted  between  1999  and  2009  investigated  the
mpact  of  a  gradual  introduction  of  field  triage  for  pPCI
nd  associated  outcomes.  Among  patients  transported  by
he  EMS  from  the  scene  of  the  event,  the  proportion  who
ere  triaged  directly  to  a  pPCI  center  in  the  field  increased
rom  33%  to  72%.30 Current  guidelines  confirm  the  impor-
ance  of  field  triage,  stating  that  the  delay  between  FMC
nd  diagnosis  should  be  reduced  to  10  min  or  less.1
In  our  study,  STEMI  patients  who  initially  attended  a  cen-
er  without  pPCI  had  significantly  longer  system  delay  than
hose  who  arrived  directly  at  a  pPCI  center.  Comparison  of
he  variables  patient  transferred  vs.  direct  to  pPCI  center
y  EMS,  as  they  relate  to  FMC-to-ECG  time  ≤10  min,  system
elay  ≤90  min,  and  total  ischemic  time  ≤120  min,  suggests
hat  attending  a  center  without  pPCI  is  a  strong  predictor  of
rolonged  system  delay.  Significantly  more  patients  trans-
orted  directly  to  a  pPCI  center  by  the  EMS  had  a  system
elay  of  ≤90  min.  In  the  worst-case  scenario  (patient  trans-
erred),  prolonged  delay  is  closely  related  to  time  spent  in
he  first  hospital  (door-in-door-out)  and  with  inter-hospital
ransfer.  Some  studies  suggest  that  door-in-door-out  time  is
ssociated  with  patient  management  in  the  emergency  room
f  the  non-pPCI  hospital.16,31
Although  information  campaigns  to  raise  awareness  of  MI
ave  been  conducted,  many  patients  still  do  not  call  the
MS  and  arrive  at  the  hospital  by  their  own  means.5 How-
ver,  in  some  cases  admission  to  a  center  without  pPCI  may
e  through  the  EMS.  This  does  not  always  imply  a  system  fail-
re;  one  study  suggested  that  these  delays  are  often  due  to
iagnostic  uncertainty  instead.  Of  patients  with  suspected
TEMI  who  called  112,  only  53%  were  in  fact  transported  by
n  EMS  ambulance.  In  the  other  cases,  the  national  refer-
al  center  for  emergency  patients  (CODU)  did  not  activate
MS  transportation  for  two  main  reasons:  there  were  no  EMS
ehicles  available,  or  the  patients  were  misdiagnosed.  In
oth  cases,  the  patients  were  transported  by  the  fire  depart-
ent  and  not  by  EMS  ambulance,  as  should  have  occurred.
n  a  Canadian  study,  patients  requiring  pPCI  and  undergo-
ng  inter-hospital  transfer  had  longer  symptom-call  times,
ower  ECG  ST-elevation  scores,  and  more  protocol-negative
CGs  at  presentation.32
Regarding  transferred  patients,  our  results  suggest  a  pos-
tive  trend,  with  a  significant  decrease  being  observed  over
he  course  of  the  study.  Nevertheless,  there  are  some  actions
hat  can  still  be  implemented  to  improve  the  outcomes
f  transferred  patients,  as  suggested  in  a  five-year  study
n  the  USA,  in  which  a  program  of  rapid  triage,  transfer,
nd  treatment  of  STEMI  patients  implemented  in  a  rural
rea  reduced  in-hospital  mortality  and  produced  progressive
mprovements  in  door-to-balloon  time.33
Raising  public  awareness,  including  strengthening  and
mproving  campaigns  to  publicize  the  onset  of  MI  symptoms
nd  to  encourage  people  to  call  the  112  emergency  number,
ould  help  reduce  system  delay.
Our  results  indicate  that  system  id  not  decrease  over
he  course  of  the  SFL  initiative,  but  this  does  not  mean
hat  the  initiative  was  unsuccessful.  Over  little  more  than
 decade,  the  use  of  pPCI  tripled  in  Portugal.34 The
rst  centers  to  perform  pPCI  were  located  in  the  largest
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angiography  room.  In  these  urban  centers,  secondary  trans-
port  was  practically  non-existent  and  few  patients  called
112.  Thus,  system  delay  was  estimated  on  the  basis  of
door-to-balloon  time  only.  The  spread  of  pPCI  to  periph-
eral  centers  and  more  frequent  112  calls  led  to  an  increase
in  system  delay,  mainly  due  to  increased  use  of  secondary
transport.  At  the  same  time,  primary  transport  by  EMS
also  increased,  which  also  increased  system  delay.  In  fact,
although  the  system  has  become  more  efficient,  the  clock
now  starts  ticking  as  soon  as  FMC  occurs,  before  arrival  at
the  hospital.
In  the  intermediate  stage  of  such  an  initiative,  while  the
system  is  still  adapting  and  expanding,  conventional  quality
indicators  such  as  patient  delay,  system  delay  and  door-
to-balloon  time  are  not  sufficiently  sensitive  to  assess  how
the  initiative  is  developing.  The  percentages  of  patients
who  call  112,  who  go  directly  to  secondary  hospitals  and
who  are  transported  by  EMS  may  be  more  sensitive  and
earlier  indicators  that  can  be  used  to  measure  a  positive
evolution.
Our  study  has  some  limitations.  Data  were  only  collected
on  patients  treated  by  pPCI,  so  they  cannot  be  generalized
to  all  STEMI  patients.  In  addition,  the  survey  only  covered
one  month  in  each  year,  which  means  the  possible  effects
of  seasonal  factors  on  the  results  were  not  addressed.
For  this  reason,  future  surveys  should  collect  data
continuously.
In  conclusion,  this  study  showed  that  system  delay  did
not  change  significantly  during  the  study  period.  However,
it  revealed  that  the  variables  age  ≥75  years,  attending  a
center  without  pPCI,  and  Central  region  were  significantly
associated  with  prolonged  system  delay,  whereas  calling  112
was  clearly  associated  with  shorter  system  delay.  Based  on
these  factors,  objective  measures  can  be  taken  to  reduce
system  delay  and  to  improve  clinical  outcomes  in  Portuguese
STEMI  patients.  However,  efforts  to  improve  outcome  should
not  simply  address  a  single  quality  measurement  but  should
instead  embrace  a  broader  spectrum  of  procedures  in  MI
care.
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he  authors  state  that  they  have  no  funding  to  declare.
onflicts of interest
he  authors  have  no  conflicts  of  interest  to  declare.
cknowledgments
he  authors  gratefully  acknowledge  all  centers  that  partici-
ated  in  the  Stent  for  Life  Initiative  Portugal  between  2011
nd  2015.
eferences
1. Steg PG, James SK, Atar D, et al. ESC Guidelines for the manage-
ment of acute myocardial infarction in patients presenting with
ST-segment elevation. The Task Force on the management of ST-
segment elevation acute myocardial infarction of the European
Society of Cardiology (ESC). Eur Heart J. 2012;33:2569--619.
2. O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA
guideline for the management of ST-elevation myocardial
infarction: a report of the American College of Cardiology
Foundation/American Heart Association Task Force on Practice
Guidelines. J Am Coll Cardiol. 2013;61.
3. Keeley EC, Grines CL. Primary coronary intervention for acute
myocardial infarction. JAMA. 2004;291:736--9.
4. Authors/Task Force members, Windecker S, Kolh P, et al.
2014 ESC/EACTS Guidelines on myocardial revascularization:
the Task Force on Myocardial Revascularization of the Euro-
pean Society of Cardiology (ESC) and the European Association
for Cardio-Thoracic Surgery (EACTS) Developed with the
special contribution of the European Association of Percu-
taneous Cardiovascular Interventions (EAPCI). Eur Heart J.
2014;35:2541--619.
5. Bray JE, Stub D, Ngu P, et al. Mass media campaigns’ influ-
ence on prehospital behavior for acute coronary syndromes: an
evaluation of the Australian Heart Foundation’s Warning Signs
Campaign. J Am Heart Assoc. 2015;4:e001927.
6. De Luca G, Suryapranata H, Zijlstra F, et al. Symptom-onset-to-
balloon time and mortality in patients with acute myocardial
infarction treated by primary angioplasty. J Am Coll Cardiol.
2003;42:991--7.
7. De Luca G, Suryapranata H, Ottervanger JP, et al. Time delay
to treatment and mortality in primary angioplasty for acute
myocardial infarction: every minute of delay counts. Circula-
tion. 2004;109:1223--5.
8. McNamara RL, Wang Y, Herrin J, et al. Effect of door-to-balloon
time on mortality in patients with ST-segment elevation myocar-
dial infarction. J Am Coll Cardiol. 2006;47:2180--6.
9. Nallamothu BK, Bradley EH, Krumholz HM. Time to treatment
in primary percutaneous coronary intervention. N Engl J Med.
2007;357:1631--8.
0. Bates ER, Jacobs AK. Time to treatment in patients with STEMI.
N Engl J Med. 2013:889--92.
1. Menees DS, Peterson ED, Wang Y, et al. Door-to-balloon time
and mortality among patients undergoing primary PCI. N Engl J
Med. 2013;369:901--9.
2. Denktas AE, Anderson HV, McCarthy J, et al. Total ischemic
time: the correct focus of attention for optimal ST-segment
elevation myocardial infarction care. JACC: Cardiovasc Interv.
2011;4:599--604.
3. Deutsch SB, Krivitsky EL. Decreased door to balloon time: better























4. Terkelsen CJ, Sorensen JT, Maeng M, et al. System delay and
mortality among patients with STEMI treated with primary per-
cutaneous coronary intervention. JAMA. 2010;304.
5. Postma S, Dambrink J-HE, Gosselink ATM, et al. The influence of
system delay on 30-day and on long-term mortality in patients
with anterior versus non-anterior ST-segment elevation myocar-
dial infarction: a cohort study. Open Hear. 2015;2.
6. Rathore SS, Curtis JP, Chen J, et al. Association of door-to-
balloon time and mortality in patients admitted to hospital with
ST elevation myocardial infarction: national cohort study. BMJ.
2009;338:b1807.
7. Widimsky P, Fajadet J, Danchin N, et al. Stent 4 Life targeting
PCI at all who will benefit the most: a joint project between
EAPCI, Euro-PCR EUCOMED and the ESC Working Group on Acute
Cardiac Care. EuroIntervention. 2009;4:555--7.
8. Pereira H, Pinto FJ, Calé R, et al. Stent for Life in Portugal: this
initiative is here to stay. Rev Port Cardiol. 2014;33:363--70.
9. Loh JP, Satler LF, Pendyala LK, et al. Use of emergency medi-
cal services expedites in-hospital care processes in patients
presenting with ST-segment elevation myocardial infarction
undergoing primary percutaneous coronary intervention. Car-
diovasc Revasc Med. 2014;15:219--25.
0. Kristensen SD, Laut KG, Fajadet J, et al. Reperfusion therapy
for ST elevation acute myocardial infarction 2010/2011: current
status in 37 ESC countries. Eur Heart J. 2014;35:1957--70.
1. Jaffe AS. Third universal definition of myocardial infarction.
Clin Biochem. 2013;46:1--4.
2. R Core Team. R: a language and environment for statistical com-
puting. Vienna, Austria: R Foundation for Statistical Computing;
2014.
3. Betriu A, Masotti M. Comparison of mortality rates in acute
myocardial infarction treated by percutaneous coronary inter-
vention versus fibrinolysis. Am J Cardiol. 2005;95:100--1.
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